September 13, 2018 Project Team Member Application – DS-8201a
09/13/2018
DS-8201a PMTA Submission Form
Clinical Cancer Research- Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
CCR Focus: Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
CCR Focus: The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations for the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
DS-8201a PTMA Announcement
Applicants, please submit the form to the NRG protocol development office by COB Wednesday, September 26, 2018. NRG Oncology will submit the application to CTEP by the deadline of October 3, 2018.
BackStay current with science. Sign up for our newsletter.
Support NRG Oncology.
Help Our Cause.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More